Medical and Healthcare Writing – References, Reviews, and Publications
The following is just a small selection, please contact me for additional information.
REVIEWS
“Dr. Nicola Donelan immediately embraced our project despite our short timeline. She jumped on board with gusto, worked tirelessly to meet our deadlines, and produced a stellar product that we were both proud of and incredibly grateful for. I share this journey so that you can understand our interaction with Dr. Donelan, whose professionalism is second to none and exceptional.”
“We gave Dr. Nicola Donelan the daunting task of taking an Operational Strategic Plan for Research, written by over twenty-five scientists and making it sound like one voice. Despite the short time frame she was given to perform this job, her performance was flawless.”
“I had the pleasure of working with Nicola to develop the curriculum for a number of courses in the field of Biomedical Sciences. We contracted her as a freelance medical writer to provide subject-matter expertise across a variety of subjects and to write and edit original instructions. Her work was well-researched, thoughtful, and meticulously presented. Nicola herself was consistently professional, dependable with deadlines, and always willing to work with us on revisions requested by the client. She was a pleasure to work with, and I highly recommend her services.”
“Nicola Donelan provided expert assistance in updating a systematic review, delivering work that was detailed, accurate, and insightful. Her expertise as a medical writer was evident throughout the project. Nicola was prompt and thorough in addressing all aspects of the update. I would highly recommend her for any medical writing needs.”
“I recently worked with Dr. Nicola Donelan preparing a manuscript that we gave her as a first rough draft. She developed it into a polished finished product, which is now ready for submission to a high-impact journal. Her patience, professionalism, and attention to detail were exceptional, and I highly recommend Nicola’s science writing services.”
“I am a busy dermatologist and needed to publish some studies, but finding the time to do so was very challenging. Nicola was able to edit a manuscript for me in a very short time and have it ready for publication. She understood the medical science aspect of my research, so her edits and suggestions to improve my paper were right on target. I will definitely be using her expert services in the future.”
“I recently worked with Nicola to prepare two manuscripts for publication. She developed them nicely into polished, finished products. Her patience, quick response, commitment, accuracy, useful suggestions, writing skills, professionalism, and attention to detail were remarkable.”
REFERENCES
David Flanagan
Clinical Trial Manager, Janssen Pharma (J&J), Boston, MA, USA.
Adolfo Garcia-Sastre Ph.D
Professor of Medicine and Microbiology and co-director of the Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mt. Sinai, New York, USA.
Selvon St. Clair, MD, Ph.D
Orthopedic Surgeon, Orthopaedic Institute of Ohio, Lima, USA.
Saud Sadiq, MD
Director and Chief Research Scientist, Tisch MS Research Center of New York, USA.
David Liebowitz, MD, Ph.D
Chief Medical Officer, Vaxart Inc, San Francisco, USA.
Many more on request
SELECT PUBLICATIONS
20th Annual Indy Hematology Review 2023
21st Annual Indy Hematology Review 2024
Sonidegib Duration of Response in Advanced Basal Cell Carcinoma
The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
Donelan NR, Dauber B, Wang X, Basler CF, Wolff T, García-Sastre A. J Virol. 2004 Nov;78(21):11574-82.
A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.
Donelan NR, Basler CF, García-Sastre A. J Virol. 2003 Dec;77(24):13257-66.
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.
Ludwig S, Wang X, Ehrhardt C, Zheng H,
Donelan N, Planz O, Pleschka S, García-Sastre A,Heins G, Wolff T. J Virol. 2002 Nov;76(21):11166-71
Cerebrospinal fluid screening for evidence of Epstein Barr virus presence in multiple sclerosis
N Donelan, J Dinzey, J Lin, EW Brydon, SA Sadiq
MULTIPLE SCLEROSIS (2008) Volume 14, S120-S120
Fetuin-A as a biomarker for multiple sclerosis
SA Sadiq, NR Donelan, QJ Yan
US Patent 7,790,402 (2010)
Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis
VK Harris, N Donelan, QJ Yan, K Clark, A Touray, M Rammal, SA Sadiq
Multiple Sclerosis Journal (2013) 19 (11), 1462-1472